BCAM
Boston Common Asset Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Buy |
150,862
+15,550
| +11% | +$1.22M | 0.33% | 112 |
|
|
2025
Q1 | $9.81M | Sell |
135,312
-17,220
| -11% | -$1.25M | 0.3% | 118 |
|
|
2024
Q4 | $11.3M | Sell |
152,532
-55,392
| -27% | -$4.1M | 0.33% | 112 |
|
|
2024
Q3 | $13.7M | Buy |
207,924
+7,973
| +4% | +$526K | 0.36% | 104 |
|
|
2024
Q2 | $18.5M | Sell |
199,951
-5,319
| -3% | -$491K | 0.47% | 78 |
|
|
2024
Q1 | $19.6M | Sell |
205,270
-20,836
| -9% | -$1.99M | 0.47% | 76 |
|
|
2023
Q4 | $17.2M | Sell |
226,106
-9,314
| -4% | -$710K | 0.39% | 97 |
|
|
2023
Q3 | $16.3M | Buy |
235,420
+17,928
| +8% | +$1.24M | 0.39% | 98 |
|
|
2023
Q2 | $20.5M | Buy |
217,492
+23,123
| +12% | +$2.18M | 0.44% | 86 |
|
|
2023
Q1 | $16.1M | Buy |
+194,369
| New | +$16.1M | 0.33% | 114 |
|
|
2022
Q3 | – | Sell |
-2,354
| Closed | -$224K | – | 259 |
|
|
2022
Q2 | $224K | Buy |
2,354
+185
| +9% | +$17.6K | 0.01% | 251 |
|
|
2022
Q1 | $255K | Sell |
2,169
-233
| -10% | -$27.4K | 0.01% | 246 |
|
|
2021
Q4 | $311K | Buy |
2,402
+329
| +16% | +$42.6K | 0.01% | 233 |
|
|
2021
Q3 | $235K | Buy |
2,073
+17
| +0.8% | +$1.93K | 0.01% | 241 |
|
|
2021
Q2 | $213K | Buy |
+2,056
| New | +$213K | 0.01% | 250 |
|